Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 26Gynecologic 16CNS 7Breast 5Lymphoid 4Other neoplasm 3Other hematologic neoplasm 2Head & Neck 2Gastrointestinal 2Sarcoma 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Leukoplakia 1Leukokeratosis, Hereditary Mucosal 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Imiquimod × Head & Neck × Clear all
NCT07210775 2026-03-04

Topical Imiquimod Treatment of Oral Dysplasia

University of Southern California

Phase 1/2 Recruiting
20 enrolled
DermatologicHead & Neck

Leukoplakia, Leukokeratosis, Hereditary Mucosal

NCT04883645 2025-01-28

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

Medical University of South Carolina

Phase EARLY_PHASE1 Completed
16 enrolled 10 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡